ADIPOQ and hepatocellular carcinoma: Our findings indicated that the high/positive expression of AdipoQ in liver cancer patients was significantly associated with decreased OS, which is similar to a meta-analysis of 10 studies, which revealed that increased AdipoQ expression is associated with poor prognosis in cancer patients (including HCC patients) [58].